Gibbons Patric W, Chai Peter R, Erickson Timothy B
Department of Emergency Medicine, Division of Medical Toxicology, Brigham and Women's Hospital, Massachusetts General Hospital, Boston, USA.
Department of Psychosocial Oncology and Palliative Care, Dana Farber Cancer Institute, Boston, USA.
J Cardiol Case Reports. 2022;5(1). Epub 2022 Jan 27.
We present a unique case of a massive calcium channel antagonist overdose in a patient with a permanent pacemaker. Upon presentation after the acute overdose, the patient's cardiac device was found to be pacing to an adequate rate (75 beats per minute) and she was admitted to the cardiac intensive care unit. Approximately 24 hours after her ingestion, she acutely decompensated and became hypotensive. The patient was started on infusions of norepinephrine, epinephrine, phenylephrine, and vasopressin. Her mean arterial pressure was unresponsive to multi-vasopressor therapy. She was then given a bolus of methylene blue and high-dose insulin euglycemic therapy. Despite these treatments, the patient remained hypotensive Therefore, intralipid emulsion therapy and IV epinephrine pushes were also administered. As a result of her shock and hemodynamic instability, her course was further complicated by hypoxemic respiratory failure for which she required ventilatory support and developed oliguric renal failure for which she was initiated on continuous veno-venous hemofiltration. This case emphasizes the challenges in managing complex physiology associated with nodal agent toxicity and is the first, to our knowledge, to describe management in a patient who already had a pacemaker, though it was ultimately ineffective in avoiding the patient's profound decompensation.
我们报告了一例植入永久性起搏器患者发生大量钙通道拮抗剂过量的独特病例。急性过量服药后就诊时,发现患者的心脏装置以适当的速率起搏(每分钟75次心跳),她被收入心脏重症监护病房。服药后约24小时,她突然病情恶化并出现低血压。患者开始输注去甲肾上腺素、肾上腺素、去氧肾上腺素和血管加压素。她的平均动脉压对多种血管升压药治疗无反应。随后给她静脉推注亚甲蓝并采用高剂量胰岛素正常血糖疗法。尽管进行了这些治疗,患者仍处于低血压状态。因此,还给予了脂质乳剂疗法和静脉推注肾上腺素。由于她休克且血流动力学不稳定,她的病情因低氧性呼吸衰竭而进一步复杂化,为此她需要通气支持,还出现了少尿性肾衰竭,为此开始进行持续静脉-静脉血液滤过。本病例强调了处理与钙通道拮抗剂毒性相关的复杂生理状况时面临的挑战,据我们所知,这是首例描述对已有起搏器患者的治疗情况的病例,尽管最终未能有效避免患者的严重失代偿。